Good Phase III results for Novartis’ cancer drug (breast cancer)

Good Phase III results for Novartis’ cancer drug (breast cancer)

Submitted by admin on August 26, 2018 - 12:05pm
Source: 
GoinPharma
News Tags: 
Novartis
clinical trials
breast cancer
BYL719
alpelisib
Headline: 
Good Phase III results for Novartis’ cancer drug (breast cancer)
snippet: 

Novartis has recently announced that its investigational BYL719  (alpelisib) therapy has reached its primary endpoints in the Phase III Solar-1 clinical trial. 

Do Not Allow Advertisers to Use My Personal information